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Summary
 
Qa-1
 
b
 
 binds a peptide (AMAPRTLLL), referred to as Qdm (for Qa-1 determinant modifier),
derived from the signal sequence of murine class Ia molecules. This peptide binds with high af-
finity and accounts for almost all of the peptides associated with this molecule. Human histo-
compatibility leukocyte antigen (HLA)-E, a homologue of Qa-1
 
b
 
, binds similar peptides de-
rived from human class Ia molecules and interacts with CD94/NKG2 receptors on natural
killer cells. We used surface plasmon resonance to determine the ability of Qa-1
 
b
 
 to bind re-
lated ligands representing peptides derived from the leaders of class I molecules from several
mammalian species. All of the peptides reported to bind HLA-E bound readily to Qa-1
 
b
 
. In ad-
dition, peptides derived from leader segments of different mammals also bound to Qa-1
 
b
 
, indi-
cating a conservation of this “Qdm-like” epitope throughout mammalian evolution. We have
attempted to define a minimal peptide on a polyglycine backbone that binds Qa-1
 
b
 
. Our previ-
ous findings showed that P2 and P9 are important but not sufficient for binding to Qa-1
 
b
 
. Al-
though a minimum peptide (G
 
M
 
GGGG
 
LLL
 
) bound Qa-1
 
b
 
, its interaction was relatively
weak, as were peptides sharing five or six residues with Qdm, indicating that multiple native
residues are required for a strong interaction. This finding is consistent with the observation
that this molecule preferentially binds this single ligand.
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M
 
ost MHC class I molecules are capable of binding a
large array of individual peptides (1). In contrast, the
murine class Ib molecule, Qa-1
 
b
 
, predominantly binds a
single species (2, 3). We refer to this peptide as Qdm (for
Qa-1 determinant modifier; reference 2), and it is derived
from amino acids 3–11 of class Ia D-region–encoded mole-
cules. HLA-E, which differs from Qa-1
 
b
 
 in 55 of 181 resi-
dues in the 
 
a
 
1 and 
 
a
 
2 domains, binds leader peptides from
human class Ia molecules that are very similar to the mu-
rine class Ia leader peptide bound by Qa-1
 
b
 
 (4). HLA-E
and Qa-1
 
b
 
, unlike other class Ia molecules, have serines
rather than the conserved residues threonine and tryptophan
at positions 143 and 147 in the “F” pocket, respectively. In
the “B” pocket, HLA-E and Qa-1
 
b
 
 also share the key resi-
dues methionine and alanine at positions 45 and 67, respec-
tively. The HLA-E crystal structure reveals that side chains
of five of the nine amino acids of the bound peptide pro-
trude into the pockets of the HLA-E groove (5). Based on
this structure of HLA-E, it would be predicted that only a
few substitutions in the native Qdm peptide would be tol-
erated for binding to Qa-1
 
b
 
. This use of multiple anchors
would also account for our previous finding that the Qdm
peptide binds to Qa-1
 
b
 
 with a very high affinity (6). Here,
we test this issue by examining the ability of class I leader–
derived peptides from several mammalian species to bind
Qa-1
 
b
 
 and define a minimum Qa-1
 
b
 
 binding peptide. Using
surface plasmon resonance (SPR), we find that Qa-1
 
b
 
 binds
class I leader peptides from almost all species tested. Unlike
most class Ia molecules, the binding of peptide to Qa-1
 
b
 
 re-
quires the retention of multiple amino acids from the native
Qdm peptide sequence. The fact that this single peptide
dominates the occupancy of Qa-1
 
b
 
/HLA-E may also be re-
lated to the functional properties of these molecules, since
recent data show that HLA-E interacts with CD94/NKG2
receptors on NK cells to deliver an inhibitory signal (7, 8).
 
Materials and Methods
 
Cells. Drosophila melanogaster
 
 cells (S2 cells) cultured at room tem-
perature in Schneider’s medium (Life Technologies, Inc., Gaithers-
burg, MD) supplemented with 10% fetal bovine serum (Hyclone,
Logan, UT) were cotransfected with pRMHa-3/Qa-1
 
b
 
 truncated
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b
 
(12 
 
m
 
g), pRMHa-3/
 
b
 
2
 
-microglobulin (
 
b
 
2
 
m) murine (12 
 
m
 
g),
and phshsneo (1
 
m
 
g) using the calcium-phosphate precipitation
method (9).
 
Cloning Soluble Qa-1
 
b
 
 for the Production of Soluble Molecules.
 
Total mRNA isolated from spleen cells of a C57BL/6 mouse
(RNA STAT-60; Tel-Test, Inc., Friendswood, TX) was the
template in the synthesis of first strand cDNA with reverse tran-
scriptase (SuperScript II RT; Life Technologies, Inc.) that used
oligo(dT)
 
12–18
 
 as a primer. Qa-1
 
b
 
 cDNA was synthesized by PCR
with oligonucleotides 5
 
9
 
-GTGAGGATGTTGCTTTTTGCCC
and 5
 
9
 
-TCATGCCTTCTGAGGCCAGTC. The truncated Qa-1
 
b
 
(consisting of the leader, 
 
a
 
1, 
 
a
 
2, and 
 
a
 
3 domains with an attached
[His]
 
6
 
-tag) cDNA was cloned into the modified vector pRMHa-3
(9). sH2-M3 was a gift from Dr. Johann Deisenhofer (University
of Texas Southwestern Medical Center at Dallas).
 
Production of Soluble Qa-1
 
b
 
.
 
Soluble (s)Qa-1
 
b
 
 from the super-
natant of stably transfected 
 
Drosophila
 
 cells was concentrated 10-
fold, loaded onto a C10/10 column packed with 6 ml of Ni-Nta
agarose (QIAGEN Inc., Chatsworth, CA) and eluted with 150
mM imidazole (pH 7.4). The protein was further purified by ion
exchange chromatography (Mono Q; Amersham Pharmacia Bio-
tech, Inc., Piscataway, NJ).
 
SPR.
 
All binding experiments were performed on a Biacore
2000 (Biacore International AB, Uppsala, Sweden) at 25
 
8
 
C. Cys-
teine-substituted analogue peptides of Qdm were immobilized to
the biosensor surface (Sensor Chip CM5; Biacore International
AB) using an approach similar to that described by Khilko et al.
(10). The peptides were immobilized via thioether coupling to
the biosensor flow cell, and Qa-1
 
b
 
 was run over it in the soluble
phase. In brief, upon activation of the surface with 
 
N
 
-hydroxyl-
succinimide (NHS)-
 
N
 
-ethyl-
 
N
 
9
 
(dimethylaminopropyl)carbodiim-
ide (EDC), amino groups were generated by a 10-min injection
of 1 M ethylenediamine (pH 8.5; Sigma Chemical Co., St. Louis,
MO). This was followed by a 4-min introduction of reactive ma-
leimido groups from 50 mM sulfo-SMCC (Pierce Chemical Co.,
Rockford, IL) in 25 mM sodium bicarbonate, pH 8.5. The cys-
teine-substituted peptide analogue QdmC5 (200 
 
m
 
M in 10 mM
sodium acetate, pH 5.0, except in Fig. 1, 
 
B
 
 and 
 
C
 
, where the
QdmC5 concentration was 500 
 
m
 
M) was run over the biosensor
surface for 10 min. Unreacted maleimido groups were inactivated
by a 2-min exposure to 0.1 M sodium hydroxide. All immobili-
zation steps were performed using a flow rate of 5 
 
m
 
l/min, except
the step in which cysteine-substituted peptides were run at 2 
 
m
 
l/
min. The flow rate for peptide binding experiments was 1 
 
m
 
l/min.
 
Peptide Synthesis.
 
Peptides were synthesized using F-MOC
chemistry on a peptide synthesizer (Synergy 432A; Applied Bio-
systems, Inc., Foster City, CA).
 
Results
 
We showed previously that Qa-1
 
b
 
 predominantly binds a
single peptide species, Qdm (AMAPRTLLL; reference 3).
This result precludes our ability to identify anchor residues
by conventional techniques. Therefore, the approach used in
this investigation was to generate sQa-1
 
b
 
 molecules and test
their binding ability to a series of related ligands using SPR.
To study antigen binding to the Qa-1
 
b
 
 molecule, re-
combinant sQa-1
 
b
 
/
 
b
 
2
 
m dimers were generated in 
 
D. mela-
nogaster
 
 (S2) cells following established protocols (11, 12).
Truncated Qa-1
 
b
 
 molecules secreted by stably transfected
cells were purified on Ni-coated beads followed by anion
exchange. Both heavy chain and 
 
b
 
2
 
m were visible on Coo-
massie-stained SDS-PAGE (Fig. 1 
 
A
 
).
 
Binding of Qa-1
 
b
 
 to Immobilized Qdm Peptide Is Specific and
Concentration Dependent.
 
Due to the SPR limitations in
detecting the binding of small molecular weight peptides to
immobilized class I molecules, we decided to attach the
peptide to the chip. In the following experiments, we used
QdmC5 (arginine
 
®
 
cysteine substitution at position 5),
which readily bound to the biosensor chip and in turn was
bound by sQa-1
 
b
 
 (Fig. 1, 
 
B
 
 and 
 
C
 
). This binding is specific,
since sM3 (Fig. 1 
 
B
 
) and sCD1 (not shown) failed to bind.
Binding of Qa-1
 
b
 
 to immobilized QdmC5 was blocked by
adding QdmC5 or Qdm in solution, but not irrelevant
control peptides (YPHFMPTNL) or (PMLTMCHAL), the
latter of which contains the putative Qa-1
 
b
 
 peptide anchors
methionine at P2 and leucine at P9 (Fig. 1 
 
C
 
).
Figure 1. Characteristics of sQa-1b/b2m secreted from transfected D. melanogaster cells and its specific binding to immobilized QdmC5 peptide. (A)
After concentration and purification, the supernatant from Qa-1b/b2m-transfected Drosophila cells was resolved on a 15% SDS-PAGE, and stained using
Coomassie brilliant blue. Arrows, Qa-1b heavy chain (Hc) and b2m. (B–D) SPR demonstrating binding of sQa-1b/b2m to immobilized QdmC5. Sensor-
grams were obtained using injection volumes of 20 ml at a rate of 1 ml/min. Mass increase due to macromolecular binding is measured in resonance units
(RU). Arrowheads, Start (­) and end (¯) of the injection. (B) Injection of 0.5 mM sQa-1b or sM3. (C) 0.5 mM sQa-1b was run over the chip alone, or in
the presence of 20 mM Qdm (AMAPRTLLL), QdmC5 (AMAPCTLLL), or two control peptides, PMLTMCHAL and YPHFMPTNL. (D) 0.5 mM
sQa-1b was run at 1 ml/min for 20 min over immobilized QdmC5 in the absence or presence of competitor peptides. Results are presented as relative
binding of sQa-1b, where 0 represents binding in the presence of 20 mM Qdm (25 RU), and 1 is the binding in the absence of peptide (263 RU). *, 1,
and O represent binding in the presence of 20 mM of the entire 24-mer Dd leader, MGAMAPRTL and MAPRTLLLL, respectively.975 Kurepa et al. Brief Definitive Report
Trimming and Extending Qdm at the COOH Terminus Af-
fects Its Binding to Qa-1b. Since peptides in solution can
compete with immobilized QdmC5 for binding to soluble
Qa-1b, we used this approach to further analyze the peptide
binding characteristics of this molecule. The Qdm non-
amer peptide completely blocked binding at concentrations
between 200 nM and 20 mM (Fig. 1 D). Extending the
Qdm peptide by adding a leucine at position 10 (10-mer)
results in decreased binding relative to the nonamer at 20
and 2 mM concentrations, and almost no binding at 200 nM.
Trimming the Qdm peptide at the COOH end to an 8-mer
gives a similar result. A 7-mer lost virtually all of its binding
ability. We also tested the entire 24 amino acid leader of Dd
from which the Qdm peptide is derived, and found that it
failed to block the binding of Qa-1b to immobilized pep-
tides. Finally, we generated two more nonamers from the
leader or Dd. Instead of spanning from residues 3 to 11,
these peptides span amino acids 1–9 (MGAMAPRTL) and
4–12 (MAPRTLLLL). They both failed to bind to Qa-1b.
Qa-1b Binds Peptides Derived from the Leader Segment of
Human Class I Molecules. Since HLA-E and Qa-1b share
unique features in their peptide binding grooves, we tested
whether Qa-1b can bind the same human class I–derived
peptides that bind to HLA-E. We found that all of the
tested peptides except for the one originating from the
leader of HLA-A3 bound to Qa-1b (Fig. 2). All of the pep-
tides that bound to both Qa-1b and HLA-E have very sim-
ilar sequences that are derived from positions 3–11 of the
leader. Peptides with a threonine®methionine change at
P2 (HLA-B27, -35) bound less well, and this was more ev-
ident in experiments where the inhibiting peptides were ti-
trated at lower concentrations (data not shown).
MHC Class I Leader–derived Peptides from Various Mam-
mals Bind to Qa-1b. The unusual finding that HLA-E and
Qa-1b bind the same set of peptides, all derived from leader
sequences of MHC class I molecules, raises the possibility
that there is a conservation of similar epitopes in other
mammals. In fact, inspection of representative class Ia se-
quences from a variety of mammalian species reveals a con-
served “Qdm-like” epitope (Table 1). We tested the ability
of these putative peptides to bind to Qa-1b. Most of the
tested peptides, except those from dog or cow class I mole-
cules, bound well to Qa-1b (Fig. 3 A). It is likely that the
presence of the positively charged arginine at P3 of the
peptide results in weaker binding. 
Some of these leader peptides are extremely hydrophobic
and not soluble in aqueous solvents. One such peptide is
VMSPTVLLL, a Qdm-like epitope derived from the cat
class I leader. To circumvent this problem, we diluted the
peptide in 2% DMSO, where it remained soluble, and then
used 2% DMSO as a running buffer. Under these conditions,
we demonstrate that both the murine Qdm peptide and the
peptide derived from the cat sequence bind Qa-1b (Fig. 3 B).
The Minimal Requirements for Peptide Binding to Qa-1b.
We next determined the minimum requirement for ligand
binding to Qa-1b by synthesizing a number of peptides in
which glycines were introduced in different positions (Ta-
ble 2). We used glycine instead of alanine because the na-
tive Qdm sequence contains two alanines. Of the minimal
peptides we tested, those with two or three nonglycine res-
idues showed no (GMGGGGGGL, GMGGRGGGL) or
Figure 2. Blocking of the binding of sQa-1b to immobilized QdmC5
by peptides derived from leader sequences of human class I molecules.
Results are presented as relative binding, where 0 is the binding of sQa-1b
in the presence of 20 mM Qdm (32 RU), and 1 is the binding in the ab-
sence of peptides (345 RU). 0.5 mM sQa-1b was run over immobilized
QdmC5 for 20 min at the rate of 1 ml/min in the presence of 20 mM
competitor peptides. For HLA-E binding, 1 indicates strong binding, 2
indicates no binding, and 1/2 indicates weak binding. Data taken from
*Table 1 in reference 18, ‡reference 8, and §reference 4.
Table 1. Conservation of “Qdm-like” Epitope in Mammals
Qdm-like
peptides present
in class I leaders Species
Molecule
containing
sequence
AMAPRTLLLa Mouse D-end molecules
AMAPRTLLLb Rat RT1.A
AMAPRALLLc Pema Pm62
VMRPRTLLLd Cow BL3-7
VMRPRTLLLe Dog DLA-6.7B
VMSPTVLLLf Cat FLA24
VMAPRTLVLg Gorilla GOGO-A0401
VMAPRTLVLh Human HLA-A2
VMPPRTLLLi Chimpanzee CHLA A-108
MAPRTLLLj Human HLA-A3
These sequences were obtained from the SWISS-PROT database, ex-
cept for c which was obtained from reference 19. Accession numbers
are  aM34962,  bL26224,  dB27638,  eS35940,  fA45897,  gP30377,
hX02883, iP13748, and iX00492.976 Peptides that Bind Qa-1b
very little binding (GMGGGGLGL, GMGGGGGLL) (Ta-
ble 2). However, a peptide with four of nine native residues
GMGGGGLLL blocked .50% of binding of sQa-1b to im-
mobilized QdmC5 peptide at the highest concentration
tested (20 mM). However, when this peptide was titrated,
we noted relatively little blocking activity at 2 mM and
none at 200 nM, in marked contrast to the titration seen
when more homologous peptides were tested (Fig. 3 A).
This indicates that methionine at P2 and the three
COOH-terminal leucines are sufficient for detectable al-
though relatively very weak binding to Qa-1b. Side chains
of other amino acids in Qdm also play a role in the overall
peptide binding. There is apparently a fine balance in their
contribution which is dependent on the neighboring resi-
dues, since a peptide with five native residues (GMGGR-
GLLL) binds better to Qa-1b than a peptide with six native
residues (GMGPRGLLL).
Discussion
Both Qa-1b (3) and HLA-E (4) bind a similar peptide
derived from the leader of class Ia molecules. It appears that
these are the major peptides that both of these class I mole-
cules bind. Although Qa-1b and HLA-E share unique resi-
dues in their F pocket that are not found in other class I mol-
ecules, it is surprising that they bind similar peptides, since
they differ considerably in their primary structure. Data
presented in this paper show that Qa-1b not only binds pep-
tides derived from the leader of murine MHC molecules,
but also binds all of the human class I–derived peptides that
were reported to interact with HLA-E, as well as putative
class I leader peptides from several other mammalian species.
An examination of leader sequences from representative class
I alleles from several mammalian species shows a conserva-
tion of the Qa-1b/HLA-E binding epitope between positions
3 and 11 of the segment. In fact, among the class I–derived
peptides we tested, there is relatively little variability in most
of the amino acids. For example, P4 (proline) and P9 (leu-
cine) had no variability, whereas P1, P2, P5, and P7 had a
single predominant residue although an alternative amino
acid was seen in some peptides. The binding of this array of
xenogeneic leader peptides was almost as efficient as the
binding of the murine leader itself. It is important to note
that leaders of Qa-1b, HLA-E, and their other mammalian
homologues are unique and do not contain the conserved
Qdm-like epitope. Consequently, the peptide binding
grooves of these molecules are not occupied by peptides
derived from their own leaders.
We have attempted to determine the minimum motif
required for peptide binding to Qa-1b. Since only one pep-
tide has been eluted from the groove of this molecule, it is
not possible to assign anchor residues in the conventional
manner. In addition to embedding principal anchors, me-
thionine at P2 and leucine at P9, we needed to introduce
two more wild-type residues in the polyglycine chain, leu-
cines at P7 and P8, to observe detectable binding. How-
ever, the binding of this pentaglycine analogue was still
considerably weaker than that of native Qdm, suggesting
that side chains of other residues also contribute to the
overall interaction. Although it is possible that binding of
the minimal peptide with fewer anchor residues could have
been found had we used a backbone other than glycine
(13), several other minimal peptides with glycine back-
bones have been used successfully to identify anchors that
participate in binding to class I molecules (14, 15).
Thus, the finding that Qdm requires multiple anchors
would explain the dominance of a single peptide in its
Figure 3. Putative peptides from leaders of vari-
ous mammalian class I molecules bind to Qa-1b.
Results are presented at relative binding, where 0 is
the binding of sQa-1b in the presence of 20 mM
Qdm (25 RU in A, 26 RU in B), and 1 is the bind-
ing in the absence of blockers (276 RU in A, 230
RU in B). Running buffer was Hepes-buffered sa-
line (HBS) in A and 2% DMSO in HBS in B.
Table 2. Binding of Poly-Gly Peptides to Qa-1b
Peptide sequence
Qa-1b binding
[Inhibitor peptide]
20/2/0.2 mM
GMGGGGGGL 0/ND/ND
GMGGRGGGL 0/ND/ND
GMGGRGGLL 0/ND/ND
GMGGRGLGL 0/ND/ND
GMGGRGLLL* 0.74/ND/ND
GMGPRTLGL NS‡
GMGPRGLLL* 0.59/ND/ND
GMGPRGLGL 0/ND/ND
GMGGGGLLL 0.56/0.16/0
GMGGGGLGL 0.18/0/0
GMGGGGGLL 0.09/0/0
AMAPRTLLL 1/1/0.76
sQa-1b was run over immobilized QdmC5 for 20 min at the rate of 1
ml/min in the presence of different poly-Gly peptides with HBS as run-
ning buffer. Final responses were expressed as a fraction of 1, which was
maximal blocking achieved by 20 mM Qdm. A response of 0 indicates
that peptide does not bind to Qa-1b. Native residues are shown in bold.
Peptides with three or four native residues that showed some blocking
at 20 mM were further titrated versus Qdm at 2 mM and 200 nM.
*Running buffer was 2% DMSO in HBS.
‡Peptide GMGPRTLGL was not soluble (NS) in 2% DMSO in HBS.977 Kurepa et al. Brief Definitive Report
groove. The data presented here, together with the recent
crystal structure of HLA-E bound to its peptide (5), suggest
that Qa-1b and HLA-E can only bind Qdm-like peptides
with high efficiency. However, it cannot be ruled out that
their occupancy by these peptides is a result of a restrictive
peptide antigen processing and/or presentation pathway. It
is interesting to note that the common ligand that Qa-1b
and HLA-E bind is derived from a conserved part of class I
leader segments that are expendable in the mature protein
and thus would not affect selection for polymorphic pep-
tide binding residues.
Boyson et al. (16) pointed out that a comparison of the
rates of synonymous and nonsynonymous nucleotide sub-
stitutions in the peptide binding region versus the remain-
der of the molecule indicates that the peptide binding
groove of HLA-E and its homologues in macaques has
been conserved for over 36 million years, when the two
last shared a common ancestor. Yeager et al. have commu-
nicated that, although not orthologous, Qa-1b and HLA-E
might have evolved similar functions through convergent
evolution at the amino acid sequence level of the peptide
binding region (17). Regardless of whether molecular-level
convergence or evolutionary conservation of the peptide
binding region accounts for the specificity of these grooves,
this conservation of specificity suggests a crucial immuno-
logical function for these molecules. In this regard, it has
recently been shown that HLA-E is a ligand for CD94/
NKG2 receptors on NK cells; interaction of HLA-E with
this receptor protects target cells from NK-mediated lysis
(7, 8). Although this has not yet been demonstrated for
Qa-1b, it is likely that it interacts with its murine CD94/
NKG2 counterpart in a similar manner. Class I molecules
in mice could, through Qa-1b, control the activity of NK
cells which would be signaled upon interaction with cell
surface–expressed Qa-1b. Decreased expression and/or
processing of class I molecules would decrease the expres-
sion of Qa-1b, which would in turn result in a changed ac-
tivity level of NK cells.
It is conceivable that occasionally Qa-1b–bound class
I–derived peptides could be replaced, or that some of the
peptide binding grooves might be initially occupied by
other self- or pathogen-derived peptides which would be
presented to T cells. Future studies should show whether
Qa-1b is recognized by NK cell receptors, and what role
peptides play in the response.
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